Tags

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Why aren’t they requiring smallpox vaccination for those traveling to and from Nigeria and other areas with monkeypox? Smallpox vaccination reduces the risk by 85%. And, monkeypox has a 10% case fatality rate (death rate for those infected) making it far more deadly than Covid-19. So, even for those vaccinated for smallpox, it appears to be more deadly than Covid-19. The duration of the effectiveness of the smallpox vaccine is unclear, too, and mass vaccinations ended in the United States in the early 1970s. This is typical of the US government, in recent decades: allowing people who go abroad to import disease, transmit it and ultimately force everyone to get vaccinated, as was the case with Covid-19 and with measles, which had been eradicated from the United States. Rather than force foreign students to be vaccinated against measles, US universities required all students to get vaccinated and even boosters for the vaccinated.

Measles Elimination in the U.S. is undermined by unvaccinated travelers: “In 2000, measles was declared eliminated from the United States. That means the disease is no longer constantly present in this country. However, travelers continue to bring measles into the United States, and it can sometimes spread and cause outbreaks among people who are not vaccinated.” https://www.cdc.gov/measles/elimination.html Why isn’t measles vaccination, or proof of immunity, required before entrance into the country? Or vaccination for smallpox when going to and from Nigeria?

Nigeria partially evaded (dangerous) smallpox vaccination, unlike the rest of the world: “surveillance-containment or ring vaccination, led to the disappearance of smallpox in eastern Nigeria even though the population coverage was less than 50%.” Belongia and Naleway, 2003: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069029/ According to estimates by Nguyen et al., “By 2016, only 10.1% of the total population in Nigeria was vaccinated against smallpox; the serologic immunity level was 25.7% among vaccinated persons and 2.6% in the overall population. The substantial resurgence of monkeypox in Nigeria in 2017 appears to have been driven by a combination of population growth, accumulation of unvaccinated cohorts, and decline in smallpox vaccine immunity. The expanding unvaccinated population means that entire households, not just children, are now more susceptible to monkeypox, increasing risk of human-to-human transmission.“ https://wwwnc.cdc.gov/eid/article/27/4/pdfs/20-3569.pdf Ring vaccination: https://www.cdc.gov/smallpox/bioterrorism-response-planning/public-health/ring-vaccination.html And, the overlords of the United States have been importing over a million legal immigrants per year and now millions more illegal, so that we will be overcrowded, and disease spread more easily.

According to Stat News, “More than 200 people in 27 states are being monitored for possible exposure to monkeypox after they had contact with an individual who contracted the disease in Nigeria before traveling to the United States this month, according to the Centers for Disease Control and Prevention”. Those exposed were to be monitored by State and local health authorities until July 30th (21 days). Monitored individuals include those sitting within 6 feet of the individual on the flight from Lagos to Atlanta, those who used the same toilet, those who cleaned the toilet. See: “More than 200 people in U.S. being monitored for possible monkeypox exposure, CDC says” By Helen Branswell, July 20, 2021, Stat News https://archive.is/2LbnI (We were unable to find the original CDC information.)

Monkeypox is airborne, although hopefully not as contagious as Covid-19 or the flu. The history of monkeypox, which was discovered in lab monkeys in Africa ca 1958, looks like vaccine experiments which went wrong. It first appeared in humans in 1970, during the push to eradicate smallpox through vaccination: “Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘monkeypox.’
The first human case of monkeypox was recorded in 1970 in the Democratic Republic of Congo during a period of intensified effort to eliminate smallpox.”

And, yes, of course, if you were exposed to monkeypox they want you to consider revaccination for smallpox, even though it’s apparently a dangerous vaccine.

Is this the real reason for the new mask rules? We would guess, yes, except the Biden regime and Pelosi-Dems/Cheney Repubs apparently want multigenerational Americans to be eradicated, so we doubt they would do anything to protect us from disease. Rather, they would apparently see it as an opportunity to turn us into Pharma guinea pigs. They won’t require vaccination of illegal migrants, but are increasingly forcing Americans to take the experimental Covid vaccines.

“Transmission of monkeypox virus occurs when a person comes into contact with the virus from an animal, human, or materials contaminated with the virus. The virus enters the body through broken skin (even if not visible), respiratory tract, or the mucous membranes (eyes, nose, or mouth)… Human-to-human transmission is thought to occur primarily through large respiratory droplets. Respiratory droplets generally cannot travel more than a few feet… Other human-to-human methods of transmission include direct contact with body fluids or lesion material, and indirect contact with lesion material, such as through contaminated clothing or linens.” https://www.cdc.gov/media/releases/2021/s0716-confirm-monkeypox.html

The original has this nonsensical statement: “Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required.” It doesn’t take prolonged contact for someone to get respiratory droplets on another person!

“2021 Travel-Associated United States Monkeypox Case: On July 15, 2021, a case of human monkeypox was confirmed in a U.S. resident who traveled from Nigeria to the United States. The investigation is ongoing at this time” (last updated July 21, 2021).

“Laboratory testing at CDC showed this to be a strain of monkeypox seen in parts of West Africa, including Nigeria. While human-to-human transmission is rare, infections with this strain of monkeypox are fatal in about 1 in 100 people who become infected. However, rates can be higher in people who have weakened immune systems.” https://www.cdc.gov/poxvirus/monkeypox/2021-US-travel-case.html (They claim that the person is a US citizen but previously they called the person a US resident. Which is it? Cameroon News Today said that the person got it from a hospital in Niger (which is next to Nigeria) and that he flew out of Lagos, Nigeria to Atlanta and then to Dallas. So, was this a CDC and/or medical worker?)

“CDC recommends that the [smallpox] vaccine be given within 4 days from the date of exposure [to monkeypox] in order to prevent onset of the disease. If given between 4–14 days after the date of exposure, vaccination may reduce the symptoms of disease, but may not prevent the disease.” https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html

Before the current case, cases of Monkeypox were found in travelers coming from Nigeria in the UK, Singapore and Israel.

“CDC and Texas Confirm Monkeypox In U.S. Traveler Media Statement
For Immediate Release: Friday, July 16, 2021
The Centers for Disease Control and Prevention (CDC) and the Texas Department of State Health Services confirmed on July 15 a case of human monkeypox in a U.S. resident who recently traveled from Nigeria to the United States.

The person is currently hospitalized in Dallas. CDC is working with the airline and state and local health officials to contact airline passengers and others who may have been in contact with the patient during two flights: Lagos, Nigeria, to Atlanta on July 8, with arrival on July 9; and Atlanta to Dallas on July 9.

Travelers on these flights were required to wear masks as well as in the U.S. airports due to the ongoing COVID-19 pandemic. Therefore, it’s believed the risk of spread of monkeypox via respiratory droplets to others on the planes and in the airports is low.

Working with airline and state and local health partners, CDC is assessing potential risks to those who may have had close contact with the traveler on the plane and specific settings.

Monkeypox is a rare but potentially serious viral illness that typically begins with flu-like illness and swelling of the lymph nodes and progresses to a widespread rash on the face and body. Most infections last 2-4 weeks. Monkeypox is in the same family of viruses as smallpox but causes a milder infection. In this case, laboratory testing at CDC showed the patient is infected with a strain of monkeypox most commonly seen in parts of West Africa, including Nigeria.

Infections with this strain of monkeypox are fatal in about 1 in 100 people.

However, rates can be higher in people who have weakened immune systems.

Prior to the current case, there have been at least six reported monkeypox cases in travelers returning from Nigeria (including cases in the United Kingdom, Israel, and Singapore). This case is not related to any of these previous cases. In the United Kingdom, several additional monkeypox cases occurred in people who had contact with cases.

Background on monkeypox in Africa

Experts have yet to identify where monkeypox hides in nature, but it’s thought that African rodents and small mammals play a part in spreading the virus to people and other forest animals like monkeys. People can get monkeypox when they are bitten or scratched by an animal, prepare wild game, or have contact with an infected animal or possibly animal products. Monkeypox can also spread between people through respiratory droplets, or through contact with body fluids, monkeypox sores, or items that have been contaminated with fluids or sores (clothing, bedding, etc.) Human-to-human transmission is thought to occur primarily through large respiratory droplets. Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required.

Most monkeypox outbreaks have occurred in Africa. In addition to Nigeria, outbreaks have also been reported in nine other countries in central and western Africa since 1970. Monkeypox also caused a large outbreak in people in the United States in 2003 after the virus spread from imported African rodents to pet prairie dogs.

CDC poxvirus experts have been supporting the investigation and response to Nigeria’s monkeypox flare-ups since 2017 when the disease re-emerged in Nigeria after a nearly 40-year stint with no reported cases.

During 2017, CDC sent investigators to assist the Nigerian CDC and the National Veterinary Research Institute with tracing contacts of ill patients, providing diagnostic tests, training lab staff in country to safely test samples from suspect monkeypox cases, providing diagnostic tests and capturing small mammals to test for monkeypox (which would help identify which animals carry the disease in nature).

Scientists at CDC labs in Atlanta have also provided laboratory testing, including specialized tests to identify people who may have had monkeypox and recovered, sequencing to trace outbreaks and phylogenetics to determine if clusters of cases were related. CDC continues to train Nigerian partners in how to collect wildlife to test for which animals carry the virus in nature, helping to improve the country’s ability to track monkeypox cases in people and interview community members about their interactions with local wildlife. CDC is also running trials in Democratic Republic of Congo to assess whether the smallpox vaccine Jynneos may help protect healthcare workers from contracting undiagnosed monkeypox infections from their patients.” For more information about monkeypox, visit https://www.cdc.gov/poxvirus/monkeypox/index.html ### U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world. Page last reviewed: July 16, 2021
Content source: Centers for Disease Control and Prevention“ https://www.cdc.gov/media/releases/2021/s0716-confirm-monkeypox.html

“Monkeypox is a rare disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae.

The Orthopoxvirus genus also includes variola virus (the cause of smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus.

Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘monkeypox.’

The first human case of monkeypox was recorded in 1970 in the Democratic Republic of Congo during a period of intensified effort to eliminate smallpox. Since then, monkeypox has been reported in humans in other central and western African countries. Human monkeypox infections have only been documented six times outside of Africa; in the United States in 2003 (47 cases), in both the United Kingdom (3 cases) and Israel (1 case) in 2018, in Singapore in 2019 (1 case) and in both the United Kingdom (3 cases) and the United States (1 case) in 2021.

The natural reservoir of monkeypox remains unknown. However, African rodent species are suspected to play a role in transmission.

There are two distinct genetic groups (clades) of monkeypox virus—Central African and West African. Human infections with the Central African monkeypox virus clade are typically more severe compared to those with the West African virus clade and have a higher mortality. Person-to-person spread is well-documented for Central African monkeypox virus and limited with West African monkeypox. https://www.cdc.gov/poxvirus/monkeypox/about.html

“Passeger du Texas positif à la variole du singe” By CAMEROON NEWS TODAY – 19/07/2021 https://www.cameroonmagazine.com/actualite-internationale/afrique/passager-du-texas-positif-a-la-variole-du-singe/

“Texas: un passager venant du Nigeria positif à la variole du singe” 19.07.2021 https://www.mediacongo.net/article-actualite-90350_texas_un_passager_venant_du_nigeria_positif_a_la_variole_du_singe.html

La variole du singe détectée aux États-Unis pour la première fois depuis 2003

Belongia, Edward A, and Allison L Naleway. “Smallpox vaccine: the good, the bad, and the ugly.” Clinical medicine & research vol. 1,2 (2003): 87-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069029/

“Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox” by Reed F. Johnson,1,* Srikanth Yellayi,2 Jennifer A. Cann,2 Anthony Johnson,2 Alvin L. Smith,1 Jason Paragas,2 Peter B. Jahrling,1,2 and Joseph E. Blaney1 Virology. Author manuscript; available in PMC 2012 Sep 30. Published in final edited form as: Virology. 2011 Sep 30; 418(2): 102–112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164762/

https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html

“2021 Travel-Associated United States Monkeypox Case
On July 15, 2021, a case of human monkeypox was confirmed in a U.S. resident who traveled from Nigeria to the United States. The investigation is ongoing at this time.

Overview
The Centers for Disease Control and Prevention (CDC) and the Texas Department of State Health Services confirmed on July 15, 2021 a case of human monkeypox in a U.S. citizen who recently traveled from Nigeria to the United States.

As of July 2021, CDC is working with the airline and state and local health officials to contact and assess the potential risks to airline passengers and others who may have been in contact with the patient during two flights: Lagos, Nigeria, to Atlanta on July 8, with arrival on July 9; and Atlanta to Dallas on July 9. It’s believed the risk of spread of monkeypox on the plane and in the airports is low, as travelers were required to wear masks due to the COVID-19 pandemic, and monkeypox is primarily spread through respiratory droplets. https://www.cdc.gov/poxvirus/monkeypox/transmission.html

Laboratory testing at CDC showed this to be a strain of monkeypox seen in parts of West Africa, including Nigeria. While human-to-human transmission is rare, infections with this strain of monkeypox are fatal in about 1 in 100 people who become infected. However, rates can be higher in people who have weakened immune systems.

CDC is working closely with partners to identify individuals who may have been in contact with the patient during travel, notify state health departments about potential contacts, and provide information to clinicians and epidemiologists who are identifying and monitoring contacts. Additionally, CDC has set up a call center for health departments for questions about monitoring contacts and for clinicians if monkeypox is suspected in a patient. The public should contact their local health department for questions.

Clinicians and Health Departments:
For information on identifying and monitoring patients for monkeypox, please see new guidance. https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html
Page last reviewed: July 21, 2021
Content source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP) “ https://www.cdc.gov/poxvirus/monkeypox/2021-US-travel-case.html

https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html

“Amid Smallpox Fear, Many Seek Signs of Childhood Shots” By Carol Vinzant, Special to The Washington Post https://www.ph.ucla.edu/epi/bioter/scarsearch.html

Eichner M. “Analysis of historical data suggests long-lasting protective effects of smallpox vaccination”. Am J Epidemiol. 2003 Oct 15;158(8):717-23. doi: 10.1093/aje/kwg225. PMID: 14561660.